Navigation Links
Drug shows promise in prostate cancer spread to bone
Date:12/4/2012

a median 23.9 weeks for patients taking cabozantinib, compared with 5.9 weeks for patients on placebo.

"Discontinuing randomization is not common. Stabilization of disease in advanced prostate cancer is rarely due to the natural history of the disease and is in this case due to drug effect," Smith says.

"While these initial results are promising, we are still uncertain how cabozantinib will impact the gold standard of survival," he adds.

Phase III studies have begun at some institutions, and U-M researchers are conducting a phase II study to better understand the effect cabozantinib has on bone. This drug is not offered routinely in clinical care at this time. For information about prostate cancer treatment options or clinical trials currently open at the U-M Comprehensive Cancer Center, call the Cancer AnswerLine at 800-865-1125.


'/>"/>
Contact: Nicole Fawcett
nfawcett@umich.edu
734-764-2220
University of Michigan Health System
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Genetic data shows that skin cancer risk includes more than UV exposure
2. Largest coronary artery disease study shows evidence of link between inflammation and heart disease
3. U-M study shows BPA exposure in fetal livers
4. Experimental Insomnia Drug Shows Promise
5. Young adults more likely to smoke cannabis than drink before driving, 2011 CAMH Monitor survey shows
6. Research from ASCOS Quality Care Symposium shows advances and challenges in improving the quality of cancer care
7. Most Women Who Choose Double Mastectomy Dont Need To, Study Shows
8. Imaging shows some brains compensate after traumatic injury
9. MRI shows brain disruption in patients with post-concussion syndrome
10. Huddersfield professors ground-breaking research shows just how well the 2012 Games were run
11. Networks it takes a village approach improves dementia care and informs research, study shows
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... Mozes HealthDay Reporter THURSDAY, ... 21st-century medicine, organ transplantation is nothing new. The first ... liver transplant in 1963 and the first human heart transplant ... of a patient,s entire face. One major organ still ... if one team of U.S. scientists has its way, that ...
(Date:10/31/2014)... Steven Reinberg HealthDay Reporter ... eczema may increase slightly the risk of broken bones and injured ... adults, researchers found that among 7 percent of people who had ... bone or joint injury and 0.6 percent had an injury that ... eczema, those with the skin condition had more than double the ...
(Date:10/30/2014)... of data from an institutional patient registry on ... control, 79 percent of tumors, for medically inoperable, ... from 2003 to 2012, according to research presented ... Thoracic Oncology. The Symposium is sponsored by the ... Society for Radiation Oncology (ASTRO), the International Association ...
(Date:10/30/2014)... Florida (PRWEB) October 30, 2014 Timothy, ... visit to Pompano Beach firefighters, showing that you are ... , Timothy met firefighters Tracey and Carl at ... Galuppi’s Restaurant and the Pompano Beach Chamber of Commerce. ... the fire truck, letting Timothy wear his real fireman’s ...
(Date:10/30/2014)... (PRWEB) October 30, 2014 PreDiabetes ... PreD Store shoppers with a supply of ... meals to reduce post-meal blood sugar spikes. Learning how ... is an important part of a diabetes prevention plan. ... will receive one complimentary tube of sugardown. The offer ...
Breaking Medicine News(10 mins):Health News:Scientists Set Their Sights on First Whole-Eye Transplant 2Health News:Scientists Set Their Sights on First Whole-Eye Transplant 3Health News:Eczema Tied to Bone Fracture Risk in Study 2Health News:Sustained local control for medically inoperable, early stage lung cancer patients 2Health News:Sustained local control for medically inoperable, early stage lung cancer patients 3Health News:4-year-old InstaKNOT CEO Honors Local Firefighters with Community Support 2Health News:4-year-old InstaKNOT CEO Honors Local Firefighters with Community Support 3Health News:4-year-old InstaKNOT CEO Honors Local Firefighters with Community Support 4Health News:PreDiabetes Treatment Company Offers PreD Store Shoppers Supplements to Support Healthy Blood Sugar 2
... Study Finds 73% Are From Health Care Facilities, ... on hospitals today to take more aggressive steps ... light of a new report,showing that they are ... the rate of hospital acquired C.-diff. infections has ...
... available in French . , Montreal, November ... protein patterning technique that,s enabled them to reproduce complex ... painting. According to a new study published in the ... Montral, the Maisonneuve-Rosemont Hospital Research Centre, McGill University and ...
... playing a key role in the largest, most comprehensive ... Health (NIMH) of adolescents and young adults at risk ... joins the resources of Emory and seven other major ... predictors for psychosis, and a better understanding of the ...
... may be an independent cause of excessive daytime ... occurrences. Researchers from Sweden performed polysomnography testing on ... years. The apnea-hypopnea index (AHI) was calculated, and ... or very often were considered habitual snorers. Habitual ...
... of major cardiovascular event by more ... Study may anticipate a role for genetic testing in association with ... clopidogrel prescribing, FRANKLIN LAKES, ... a study at the 2008 Scientific,Sessions of the American Heart Association that showed ...
... SAN FRANCISCO, Nov. 11 What would make 100,000 ... That question will be answered November 28, 29 at ... Episcopal Church in Burlingame on,November 30 when Issam Nemeh, ... in attendance. A cardiothoracic anesthesiologist, Dr.,Nemeh has become known ...
Cached Medicine News:Health News:New Report Shows High C-difficile Infection Rates in U.S. Hospitals 2Health News:New Report Shows High C-difficile Infection Rates in U.S. Hospitals 3Health News:New Report Shows High C-difficile Infection Rates in U.S. Hospitals 4Health News:New laser method reproduces art masterworks to protein patterns 2Health News:Pivotal Emory study focuses on teens at risk for psychosis 2Health News:Pivotal Emory study focuses on teens at risk for psychosis 3Health News:Journal CHEST: Nov. highlights 2Health News:New study: A Common Class of GI Medications Reduce Protection Against Heart Attack in Patients Taking Widely Prescribed Cardiovascular Drug 2Health News:New study: A Common Class of GI Medications Reduce Protection Against Heart Attack in Patients Taking Widely Prescribed Cardiovascular Drug 3Health News:New study: A Common Class of GI Medications Reduce Protection Against Heart Attack in Patients Taking Widely Prescribed Cardiovascular Drug 4Health News:A New Meaning of Thanksgiving: Miracles for Many, Prayers for All as Healing Services Come to San Francisco 2
(Date:10/30/2014)... 30, 2014  Nektar Therapeutics (Nasdaq: NKTR ... quarter ended September 30, 2014 on Thursday, November 6, ... Howard Robin , president and chief executive officer, will ... at 5:00 p.m. Eastern Time (ET)/2:00 p.m. Pacific Time ... live audio-only Webcast of the conference call can be ...
(Date:10/30/2014)... Oct. 30, 2014  CytRx Corporation (NASDAQ: ... company specializing in oncology, today announced an upcoming ... drug candidate, aldoxorubicin.  The presentation, titled, "Drug Conjugates ... be given by Sant P. Chawla , ... and principal investigator of the Company,s ongoing global, ...
(Date:10/30/2014)... , Extensively hydrolyzed milk formula ... Cow milk protein allergy (CMPA) is the leading cause of ... it has been managed by eliminating milk proteins from ... it is possible to help build of oral tolerance ... during the first year of life by using an ...
Breaking Medicine Technology:Nektar to Announce Financial Results for the Third Quarter 2014 on Thursday, November 6, 2014, After Close of U.S.-Based Financial Markets 2CytRx Announces Oral Presentation at 2014 Chemotherapy Foundation Symposium 2CytRx Announces Oral Presentation at 2014 Chemotherapy Foundation Symposium 3CytRx Announces Oral Presentation at 2014 Chemotherapy Foundation Symposium 4Experts Present Latest Research at Allergy Day 2Experts Present Latest Research at Allergy Day 3
... Sept. 13, 2011 Edison Pharmaceuticals, Inc. announced today ... Capital raised will fund US and European approval trials ... of the financing were not disclosed. ... is a patient- and physician-founded company devoted to developing ...
... The University of Michigan Health System has selected a ... data from medical to communications devices, wireless phones and pagers ... Voigtlander Women,s Hospital. "Moving from a facility where ... larger facility where beds are now separated into multiple rooms, ...
Cached Medicine Technology:New Hospitals to Implement New Communications Technology 2
... monomeric contrast medium for intravascular and body ... a decade of clinical experience and use ... proven to be a valuable part of ... departments.Results from large multicentre monitoring trials1-3 confirm ...
... MultiHance (gadobenate dimeglumine) is a paramagnetic ... is complexed with gadobenate, a chelating agent ... around the godolinium ion. It is salified ... is endowed with all the physico-chemical features ...
... U.S. in 1993 to provide contrast enhancement ... detect lesions of the brain, spinal cord, ... approval for adult body and high-dose CNS ... OMNISCAN comes in different sizes to accommodate ...
... When MAGNEVIST (gadopentetate dimeglumine) injection was ... revolutionary concept of contrast-enhanced magnetic resonance imaging ... agent for use in MRI. Today, the ... indications in CNS, head, neck and body. ...
Medicine Products: